logo
logo

Crescent Biopharma, Inc. Appoints Wenjie Cheng As Senior Vice President of Technical Operations, Ryan Lynch As Chief Accounting Officer, and Barbara Bispham As General Counsel

Feb 24, 2025•5 months ago

Position

Chief Accounting Officer

Company

Crescent Biopharma

Ryan Lynch
RockvilleTherapeuticsBiotechnologyHealth Care

Description

Crescent Biopharma, Inc. has announced the appointment of three industry veterans to its leadership team, reinforcing the Company's momentum in building a leading oncology therapeutics company.

Company Information

Company

Crescent Biopharma

Location

Rockville, Maryland, United States

About

Crescent Biopharma is a biotechnology company dedicated to advancing novel precision engineered molecules targeting validated biology to advance care for patients with solid tumors. The company's pipeline of three programs harnesses proven biology to accelerate the path to market for potentially best in class therapeutics. The company's lead program is CR-001, a tetravalent PD-1 x VEGF bispecific antibody; it is also advancing CR-002 and CR003, antibody-drug conjugates with topoisomerase inhibitor payloads for undisclosed targets.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months